PharmaRadar360

PharmaRadar360

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

43,499 stories, page 562 of 725

Advanced search
🌍discoverynews.google.comTier 3 · Aggregated media

ZeroStack Corp. Secures Purchase Orders for up to US$14.7 Million of Inventory from Two Pharmaceutical Companies

TMX NewsfileOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

3 High Growth GLP-1 Biotech Winners to Buy in July

24/7 Wall St.Original source
🇨🇦Regulatoryrecalls-rappels.canada.caTier 1 · Regulatory source

Phantom® Hindfoot TTC/TC Ball Tipped Guide Rod

Zimmer Biomet Canada on behalf of Paragon 28, Inc. is conducting a lot-specific medical device recal...

Health Canada Recalls and Safety AlertsOriginal source
🇨🇦Regulatoryrecalls-rappels.canada.caTier 1 · Regulatory source

ºM Warmer

A misplaced seal may cause leakage internally in the ºM Warmer device. This can lead to a shortcut o...

Health Canada Recalls and Safety AlertsOriginal source
🇨🇦Regulatoryrecalls-rappels.canada.caTier 1 · Regulatory source

Astral 150™

An internal electrical component (supercapacitor) may leak electrolyte over time. In rare cases, thi...

Health Canada Recalls and Safety AlertsOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Pharmaceutical Technology

Pharmaceutical TechnologyOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

Carbapenemase-producing Gram-negative organisms: laboratory surveillance

Quarterly reports on acquired carbapenemase-producing Gram-negative organisms (CPOs) identified in h...

UK Health Security AgencyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

H.C. Wainwright cuts Helus Pharma stock price target to $70 on dilution

Investing.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Vertex acquires Crinetics in $10bn endocrinology deal

European Pharmaceutical ReviewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

US FDA approves first-in-class treatment for kidney disease

MyJoyOnlineOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

The Billion-Dollar Pill: With NXP100, Nuvectis Pharma Just Staked Its Claim in the New Biotech Gold Rush

TradingViewOriginal source
🌍discoverynews.google.comTier 2 · Trade media

GSK cuts losses on $700M upfront Alzheimer’s collab with Alector following 2 clinical failures

Fierce BiotechOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

CervoMed finishes Phase 2 study in rare dementia with no U.S. or EU treatment

Stock TitanOriginal source
🇺🇸Industryinvestor.lilly.comTier 1 · Company source

Lilly to present Alzheimer's disease diagnostic and therapeutic research at AAIC 2026, including new data on P-tau217 blood tests and amyloid-targeting treatment

Eli Lilly NewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

ISAAA Launches Brief 57 in Manila, Marking Two Decades of Biotech Success in the Philippines

ISAAA.orgOriginal source
🇪🇺Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: ACCELERATING STROKE TREATMENT INNOVATION THROUGH AN AI-ENABLED IN-SILICO NEW APPROACH METHODOLOGY (NAM)

CORDISOriginal source
🇪🇺Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: Ultra-Scalable Genetic Programming for NAM-Ready Engineered Myotissues

CORDISOriginal source
🇪🇺Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: IRIS-VISTA: From Proof-of-Concept to Market Readiness in Predictive Neurovascular Medicine

CORDISOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

3 Reasons to Buy Novo Nordisk Stock

aol.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Illicit Gain Combating Commission widens scope, placing private pharmaceutical and higher education institutions under direct control

syriahr.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Science in Motion: The Technologies Shaping Tomorrow's Pharmaceutical Industry

Microbioz IndiaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Teva (TEVA) Advances TEV 408 Into Phase 2b For Vitiligo After Early Progress

simplywall.stOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Teva (TEVA) Advances TEV 408 Into Phase 2b For Vitiligo After Early Progress

simplywall.stOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Is Viking Therapeutics Stock Going to $100?

aol.comOriginal source
🌍discoverynews.google.comTier 2 · Trade media

931 days. The drug approval scandal hiding in plain sight

STATOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Biotech’s digital twin dilemma

NatureOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Greenwood Capital Associates LLC Sells 142,082 Shares of Teva Pharmaceutical Industries Ltd. $TEVA

MarketBeatOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Pharmaceutical Packaging Summit 2026

FoodBev MediaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Evonik Invests $100 Million in U.S. API Production

CHEManagerOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

China’s Ascent in Biotech Rousts U.S. Venture Capitalists to Adapt

WSJOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Live rats, houseflies: FDA suspends license of Mumbai's iconic 'Rustom' ice cream parlour over food safety violations

ET RetailOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Pharmaceutical Industry Adopts Disease Classification for Obesity to Align with GLP-1 Medication Market

geneonline.comOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

DHSC spending over £25,000

This series brings together all documents relating to Department of Health and Social Care (DHSC) sp...

UK Department of Health and Social CareOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

DHSC: spending over £25,000, March 2026

Reports on departmental spending over £25,000.

UK Department of Health and Social CareOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

DHSC: spending over £25,000, April 2026

Reports on departmental spending over £25,000.

UK Department of Health and Social CareOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Global Biotech Leaders Converge at UAB's BAC 2026

Mirage NewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Does Tango Therapeutics' (TNGX) Russell Growth Shift Reveal Its True Biotech Identity to Institutions?

simplywall.stOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Enterprise value to EBITDA forward of Tibet Rhodiola Pharmaceutical Holding Co. Class A – SSE:600211

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Biotech rally rests on fundamentals, M&A appetite, says ROTY's Faison (XLV:NYSEARCA)

Seeking AlphaOriginal source
🌍discoverynews.google.comTier 2 · Trade media

The quest to save Grace — and clear the way for rare disease patients everywhere

STATOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

Life Sciences Jobs Plan

A plan to ensure the UK life sciences sector has the skilled workforce it needs for future growth.

UK Department of Health and Social CareOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

Virus Reference Department (VRD): user manual

The Virus Reference Department (VRD) provides clinical advice and investigations for a wide range of...

UK Health Security AgencyOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

MRSA, MSSA, Gram-negative bacteraemia and CDI: quarterly report

Trends in meticillin resistant (MRSA) and meticillin susceptible (MSSA) Staphylococcus aureus, Gram-...

UK Health Security AgencyOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

Hand hygiene alternatives to soap and water for reducing C. difficile

A rapid systematic review on hand hygiene alternatives to soap and water for reducing C. difficile.

UK Health Security AgencyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA Plan Could Put Pharma Ads Out Of Reach For Broadcasters.

Insideradio.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

MEDIPOST enrolls and treats first patient in U.S. Phase 3 trial of CARTISTEM, advancing U.S. commercialization

더바이오Original source
🇩🇪Mediadzne.deTier 2 · Direct publisher

Cellular Metamorphosis: Scientists Uncover a Key Mechanism Behind Nerve Growth

DZNE (Neurodegenerative Diseases)Original source
🌍discoverynews.google.comTier 3 · Aggregated media

AstraZeneca stock drops 9% after heart drug trial miss deals rare blow to pharma powerhouse

CNBCOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Enterprise value to EBITDA forward of Moleculin Biotech, Inc. – NASDAQ:MBRX

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Pharmaceutical Machine Learning Market Growth to Accelerate by 2035 Amid AI-Driven Bioprocessing Advances - News and Statistics

IndexBoxOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

When Two CROs Become One, Sites Pay the Integration Tax

The Clinical Trial VanguardOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Setmelanotide Phase 3 Trial for Hypothalamic Obesity Published in NEJM

The Clinical Trial VanguardOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Maharashtra FDA Warns Against Three Beauty Creams after Tests Detect Excessive Mercury, Lead Levels

NewsGramOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA Accepts Arcutis ZORYVE Application for Atopic Dermatitis in 3-Month-Old Infants

The Clinical Trial VanguardOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Sunscreen Monograph: FDA Adds Bemotrizinol in Latest Update

HKTDC NewsbitesOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Ionis heart drug misses key goal, but monotherapy subgroup hit

Stock TitanOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Novo Nordisk launches weekly insulin shot Awiqli in India

ReutersOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Enterprise value to EBITDA forward of Jointown Pharmaceutical Group Co., Ltd. Class A – SSE:600998

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Price to sales forward of Ningbo Menovo Pharmaceutical Co., Ltd. Class A – SSE:603538

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Update on CARDIO-TTRansform Phase 3 trial of eplontersen in adults with transthyretin-mediated amyloid cardiomyopathy

Yahoo Finance SingaporeOriginal source